RegenxBio
Presence
RegenxBio is one of the...
RegenxBio is a company listed under the stock ticker RGNX (US).
Executives
View the org chart displaying its 29 main executives
Most searched biographies at RegenxBio
- Curran Simpson, President, Chief Executive Officer and Board Member
- Ken Mills, Chairman of the Board
- Alexandra Glucksmann, Director
Popular executive movements at RegenxBio
- Daniel Tassé who is Director, will be promoted to Lead Independent Director on Jul. 1, 2024 (posted on June 13 2024).
- Curran Simpson who is Chief Operating Officer, will be promoted to President, Chief Executive Officer and Board Member on Jul. 1, 2024 (posted on June 13 2024).
Create your alert
to follow the executive moves at RegenxBio.
Biotechnology
RegenxBio has 2,294 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Eurofins PSS Insourcing Solutions (United States (USA)).
Popular M&A news in Biotechnology
- Biogen has announced the acquisition of HI-Bio (posted on July 3 2024).
- N-Power Medicine has just announced a $72 Million fundraising (posted on July 2 2024).
- LB Pharmaceuticals has just announced a $75 Million fundraising (posted on June 28 2024).
Popular contacts in Biotechnology
News
Press releases by RegenxBio
- REGENXBIO Reports Second Quarter 2022 Financial Results and Recent Operational Highlights | REGENXBIO Inc.
- REGENXBIO Announces Intention to File a Biologics License Application Using the Accelerated Approval Pathway for RGX-121, an AAV Therapeutic for the Treatment of MPS II | REGENXBIO Inc.
- REGENXBIO to Host Conference Call on August 3 to Discuss Second Quarter 2022 Financial Results and Recent Operational Highlights | REGENXBIO Inc.
- REGENXBIO Announces Enrollment Complete in Cohort 5 of Phase II AAVIATE® Trial | REGENXBIO Inc.
- REGENXBIO Opens State-of-the-Art Gene Therapy Manufacturing Facility | REGENXBIO Inc.
- Jennifer Zachary Joins REGENXBIO Board of Directors | REGENXBIO Inc.
- REGENXBIO Reports First Quarter 2022 Financial Results and Recent Operational Highlights | REGENXBIO Inc.
- REGENXBIO to Participate in Upcoming Investor Conferences | REGENXBIO Inc.
- REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting | REGENXBIO Inc.
- REGENXBIO to Host Conference Call on May 4 to Discuss First Quarter 2022 Financial Results and Recent Operational Highlights | REGENXBIO Inc.
- View more press releases Close
Social media about RegenxBio
- RegenxBio on Wikipedia, Google News & Yahoo Finance
- RegenxBio on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Curran Simpson 
